Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
8
NMPA:8
Drug Approvals
Procaterol Hydrochloride Inhalation Solution
- Product Name
- 盐酸丙卡特罗吸入溶液
- Approval Number
- 国药准字H20247218
- Approval Date
- Sep 20, 2024
NMPA
Moxifloxacin Hydrochloride Eye Drops
- Product Name
- 盐酸莫西沙星滴眼液
- Approval Number
- 国药准字H20234318
- Approval Date
- Oct 18, 2023
NMPA
Procaterol Hydrochloride Inhalation Solution
- Product Name
- 盐酸丙卡特罗吸入溶液
- Approval Number
- 国药准字H20233837
- Approval Date
- Jun 30, 2023
NMPA
Ipratropium Bromide Solution for Inhalation
- Product Name
- 吸入用异丙托溴铵溶液
- Approval Number
- 国药准字H20233721
- Approval Date
- Jun 14, 2023
NMPA
Terbutaline Sulfate Nebuliser Solution
- Product Name
- 硫酸特布他林雾化吸入用溶液
- Approval Number
- 国药准字H20233444
- Approval Date
- Apr 11, 2023
NMPA
Terbutaline Sulfate Nebuliser Solution
- Product Name
- 硫酸特布他林雾化吸入用溶液
- Approval Number
- 国药准字H20233443
- Approval Date
- Apr 11, 2023
NMPA
Salbutamol Sulfate Inhalation Solution
- Product Name
- 吸入用硫酸沙丁胺醇溶液
- Approval Number
- 国药准字H20233355
- Approval Date
- Mar 24, 2023
NMPA
Salbutamol Sulfate Inhalation Solution
- Product Name
- 吸入用硫酸沙丁胺醇溶液
- Approval Number
- 国药准字H20233356
- Approval Date
- Mar 24, 2023
NMPA
Clinical Trials
No trials found
News
No news found